News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
406,260 Results
Type
Article (47425)
Company Profile (82)
Press Release (358748)
Multimedia
Podcasts (30)
Webinars (14)
Section
Business (112404)
Career Advice (1306)
Deals (15384)
Drug Delivery (47)
Drug Development (48605)
Employer Resources (92)
FDA (7617)
Job Trends (8772)
News (183571)
Policy (14174)
Tag
2027 Pharm Country Standard (1)
Academia (2614)
Academic (1)
Accelerated approval (19)
Adcomms (10)
Allergies (72)
Alliances (32782)
ALS (119)
Alzheimer's disease (1349)
Antibody-drug conjugate (ADC) (183)
Approvals (7776)
Artificial intelligence (346)
Autoimmune disease (94)
Automation (17)
Bankruptcy (88)
Best Places to Work (6896)
BIOSECURE Act (10)
Biosimilars (52)
Biotechnology (52)
Bladder cancer (79)
Brain cancer (45)
Breast cancer (398)
Cancer (3147)
Cardiovascular disease (204)
Career advice (1100)
Career pathing (27)
CAR-T (187)
CDC (23)
Cell therapy (467)
Cervical cancer (17)
Clinical research (39941)
Collaboration (1255)
Compensation (150)
Complete response letters (22)
COVID-19 (1944)
CRISPR (68)
C-suite (428)
Cystic fibrosis (100)
Data (4028)
Decentralized trials (2)
Denatured (10)
Depression (79)
Diabetes (267)
Diagnostics (3876)
Digital health (19)
Diversity (6)
Diversity, equity & inclusion (24)
Drug discovery (196)
Drug pricing (80)
Drug shortages (6)
Duchenne muscular dystrophy (134)
Earnings (44260)
Editorial (34)
Employer branding (14)
Employer resources (82)
Events (50256)
Executive appointments (545)
FDA (9305)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (3)
Frontotemporal dementia (14)
Funding (916)
Gene editing (125)
Generative AI (30)
Gene therapy (364)
GLP-1 (499)
Government (2360)
Grass and pollen (2)
Guidances (313)
Healthcare (10613)
HIV (35)
Huntington's disease (23)
IgA nephropathy (32)
Immunology and inflammation (113)
Immuno-oncology (33)
Indications (64)
Infectious disease (2095)
Inflammatory bowel disease (118)
Inflation Reduction Act (6)
Influenza (71)
Intellectual property (141)
Interviews (262)
IPO (7449)
IRA (31)
Job creations (2124)
Job search strategy (939)
JPM (24)
Kidney cancer (8)
Labor market (57)
Layoffs (281)
Leadership (14)
Legal (2411)
Liver cancer (41)
Longevity (9)
Lung cancer (403)
Lymphoma (252)
Machine learning (32)
Management (28)
Manufacturing (413)
MASH (105)
Medical device (5819)
Medtech (5841)
Mergers & acquisitions (8496)
Metabolic disorders (614)
Multiple sclerosis (105)
NASH (11)
Neurodegenerative disease (208)
Neuropsychiatric disorders (43)
Neuroscience (2165)
Neurotech (1)
NextGen: Class of 2026 (3262)
Non-profit (3589)
Now hiring (45)
Obesity (233)
Opinion (168)
Ovarian cancer (128)
Pain (101)
Pancreatic cancer (140)
Parkinson's disease (214)
Partnered (24)
Patents (246)
Patient recruitment (273)
Peanut (33)
People (33030)
Pharmaceutical (18)
Pharmacy benefit managers (8)
Phase 1 (12560)
Phase 2 (17023)
Phase 3 (13400)
Pipeline (3509)
Policy (161)
Postmarket research (1812)
Preclinical (7001)
Press Release (65)
Prostate cancer (170)
Psychedelics (27)
Radiopharmaceuticals (175)
Rare diseases (477)
Real estate (3707)
Recruiting (37)
Regulatory (11682)
Reports (33)
Research institute (2572)
Resumes & cover letters (187)
Rett syndrome (15)
RNA editing (6)
RSV (37)
Schizophrenia (100)
Series A (117)
Series B (76)
Service/supplier (10)
Sickle cell disease (65)
Special edition (16)
Spinal muscular atrophy (109)
Sponsored (30)
Startups (2154)
Stomach cancer (3)
Supply chain (44)
Tariffs (33)
The Weekly (20)
Vaccines (665)
Venture capital (35)
Weight loss (114)
Women's health (44)
Worklife (8)
Date
Last 7 days (258)
Last 30 days (958)
Last 365 days (16704)
2026 (1365)
2025 (17122)
2024 (20304)
2023 (23584)
2022 (33090)
2021 (34799)
2020 (31746)
2019 (25963)
2018 (19479)
2017 (18646)
2016 (18613)
2015 (22121)
2014 (16671)
2013 (14792)
2012 (14723)
2011 (15401)
2010 (14288)
Location
Africa (549)
Alabama (72)
Alaska (3)
Arizona (114)
Arkansas (4)
Asia (25115)
Australia (4795)
California (5849)
Canada (1909)
China (658)
Colorado (242)
Connecticut (280)
Delaware (164)
Europe (59485)
Florida (960)
Georgia (196)
Hawaii (1)
Idaho (21)
Illinois (458)
India (42)
Indiana (323)
Iowa (18)
Japan (290)
Kansas (55)
Kentucky (17)
Louisiana (14)
Maine (19)
Maryland (762)
Massachusetts (4336)
Michigan (198)
Minnesota (248)
Mississippi (3)
Missouri (79)
Montana (19)
Nebraska (13)
Nevada (52)
New Hampshire (27)
New Jersey (1875)
New Mexico (27)
New York (1869)
North Carolina (950)
North Dakota (6)
Northern California (2804)
Ohio (182)
Oklahoma (10)
Oregon (17)
Pennsylvania (1151)
Puerto Rico (6)
Rhode Island (27)
South America (591)
South Carolina (23)
Southern California (2348)
Tennessee (85)
Texas (952)
United States (21864)
Utah (157)
Vermont (1)
Virginia (149)
Washington D.C. (53)
Washington State (586)
West Virginia (2)
Wisconsin (70)
Wyoming (1)
406,260 Results for "prism research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biorep Technologies Announces First Successful Independent Research Use of the PRISM System in Islet Isolation
December 8, 2025
·
3 min read
Press Releases
Talus Bio Announces New Collaboration with PRISM BioLab to Discover Novel Modulators of Transcription Factor and Protein-Protein Interaction Targets
December 18, 2025
·
4 min read
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono
PRISM BioLab, Co. Ltd. announced that it has entered into a target-exclusive research and licensing agreement with ONO PHARMACEUTICAL CO., LTD.
April 25, 2024
·
3 min read
Press Releases
ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners
September 5, 2025
·
6 min read
Career Advice
Going With the Flow: Finding Success in Academic and Biotech Research Cultures
At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best set yourself up for success, adapt your approach to the specific scientific culture where you work.
January 21, 2026
·
6 min read
·
Manali Shah
Press Releases
4DMT Announces Positive Long-Term Data from Phase 1/2 PRISM Clinical Trial in Wet AMD Supporting 4D-150’s Potential as a Backbone Therapy with Consistent and Durable Benefit over Multiple Years
November 6, 2025
·
9 min read
Press Releases
PRISM MarketView Features Exclusive Q&A with Coya Therapeutics CEO Arun Swaminathan on Targeting Neurodegenerative Diseases Through Treg Therapies
September 4, 2025
·
6 min read
Sponsored
Disruptive Innovation in Cancer Research: The New Era of Oncology
As clinical research evolves, disruptive trial designs are reshaping how oncology advances. By integrating novel methodologies, strategic innovation, and patient-centered approaches, MEDSIR is driving a new era in cancer research, one that accelerates development, enhances efficiency, and delivers more meaningful therapeutic progress for patients worldwide.
December 15, 2025
·
9 min read
IN PARTNERSHIP WITH TAKEDA
Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.
January 5, 2026
·
5 min read
·
BioSpace Insights
FDA
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
ClearPoint Neuro, Inc. today announced it has received 510(k) clearance for its Prism Bone Anchor Accessory.
April 29, 2024
·
4 min read
1 of 40,626
Next
